NCT01657877View on ClinicalTrials.gov

Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Caries
Interventions
DRUG

Calcium sodium phosphosilicate

CSP high percentage weight by weight

DRUG

Sodium monoflurophosphate

500 to 1500 parts per million (ppm) of fluoride

DRUG

Placebo

No CSP and no fluoride

Trial Locations (1)

46202

Indiana University School of Dentistry, Indianapolis

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01657877 - Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice | Biotech Hunter | Biotech Hunter